Asia Pacific Optogenetics Market Research Report – Segmented By Sensor type, Techniques, Application, Light equipment and Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2024 to 2029)

Published: January, 2024
ID: 1150
Pages: 145

APAC Optogenetics Market Size (2022 to 2027)

The size of the optogenetics market in APAC was worth USD 4.28 billion in 2022 and estimated to reach USD 9.46 billion by the end of 2027, hiking at a CAGR of 17.20% from 2022 to 2027.

Optogenetics is an emerging medical technique that allows genetically defined populaces of neurons to be controlled using light, enabling the study of normal and abnormal brain function characteristics. The market growth for this technique is rapidly increasing as it can be applied to develop new methods to treat various illnesses such as neurological disorders, hearing impairment, and retinal diseases.

Extensive research on optogenetics is being conducted in cardiology, behavioral science, neuroscience, and ophthalmology. Optogenetics is an emerging field of biotechnology. The development of improved gene-editing techniques will boost optogenetics and make it more proper for clinical applications. The opportunities for development in optogenetics tools and neuroscience are driving the growth of the global optogenetics market.

The Asia-Pacific Optogenetics market is growing at a rapid pace. This market is driven primarily by the growing use of these tools in neuroscience and behavioral science. In addition, the growth of technology like LEDs, ytterbium-based lasers, ultrafast laser tools, and the increasing number of labs worldwide have resulted in the extensive adoption and application of this technique.

The market is held back by factors such as expensive technology, lack of awareness of these tools in developing countries, and reluctance to adopt new technology by the healthcare industry. Also, since the technology is in the nascent stage, the market is yet to develop properly.

This research report on the Asia Pacific optogenetics market has been segmented & sub-segmented into the following categories:

By Sensor Type: 

  • Genetically Encoded Calcium Indicators
  • pH Sensors
  • Neurotransmitter Release
  • Voltage-Sensitive Fluorescent Proteins

By Techniques: 

  • Archaerhodopsin
  • Channelrhodopsin
  • Halorhodopsin

By Application: 

  • Retinal Disease Treatment
  • Cardioversion
  • Neuroscience
  • Behavioral Tracking and Pacing

By Light Equipment: 

  • Lasers
  • LEDs
  • Others

By Country:  

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Regionally, Asia-Pacific, Latin America, the Middle East, and Africa are still adopting this technology. However, among these regions, Asia-Pacific is expected to be the fastest-growing regional market. Large-scale CRO activities are being done in the region, which supports the growth of the Asia-Pacific market.

Asia-Pacific is expected to develop at a significant rate in the worldwide optogenetics market during the forecast period. China, the world's second-largest economy, is expected to surpass the United States by 2027. Several neuroscience labs are expected to adopt optogenetic techniques, and ultrafast laser instruments, resulting in the Asia Pacific held a significant market position in the optogenetics market throughout the forecast period. Optogenetics has a unique advantage over other neuromodulation approaches in terms of temporal specificity and cellular accuracy. As a result, the expansion of the optogenetics market has been aided by increased research in neurology and brain sciences. It enables researchers to examine how the neurological activity patterns within specific brain cells give rise to ideas, behaviors, and memories with a previously unattainable level of accuracy.

As a result, it contributes to discovering cures and treatments for neurological and psychiatric disorders like depression, addiction, schizophrenia, and Parkinson's disease. New developments in optogenetics, such as wireless microchips, have made it possible to treat illness conveniently. The key market driver is optogenetics' improvements in brain mapping. The BRAIN Initiative (Brain Research through Advancing Innovative Neurotechnologies), a vast, collaborative, private-publicly funded project focused on getting a deeper understanding of the human brain, has enabled several advances in neuroscience.

Other factors supporting the growth of the APAC optogenetics market include rapid technological advancements such as ultrafast laser tools, LEDs, and ytterbium-based lasers. In the treatment of cutaneous and neurological diseases, effective LED therapies are applied. Researchers in LEDs, imaging, light treatment, and optogenetics have grasped the fundamentals, and as a result, they are promoting the use of LEDs in healthcare.

KEY MARKET PLAYERS:

A few prominent companies operating in the Asia pacific optogenetics market are Coherent Inc., Noldus, Thorlabs Inc., Cobalt Inc., Scientifica, Bruker, Laserglow technologies, Regenxbio Inc., Gensight, Addgene, UPenn Vector Core, and Jackson Laboratories.

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample